Heron Therapeutics (HRTX) PT Lowered to $13 at Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Heron Therapeutics (HRTX) PT Lowered to $20 at Cantor Fitzgerald
March 1, 2022 7:22 AM ESTCantor Fitzgerald analyst Brandon Folkes lowered the price target on Heron Therapeutics (NASDAQ: HRTX) to $20.00 (from $26.00) while maintaining a Neutral rating.
... MoreHeron Therapeutics (HRTX) PT Lowered to $16 at Needham & Company on Financial Overhang Concerns
March 1, 2022 6:31 AM ESTNeedham & Company analyst Serge Belanger lowered the price target on Heron Therapeutics (NASDAQ: HRTX) to $16.00 (from $24.00) while maintaining a Buy rating, following the company's most recent quarterly report.
The analyst quotes: "HRTX's 4Q21 disappointed with Zynrelef sales of $0.8MM (vs. $2.1MM in... More
Bitnile (NILE) Issues February 2022 Mining Update
March 1, 2022 6:31 AM ESTBitNile Holdings, Inc. (NYSE American: NILE), a diversified holding company (BitNile or the Company) today published an unaudited update on Bitcoin production and miner installation. The number of miners and production capacity metrics within this press release represent the S19j Pro Antminers at the Michigan data center. BitNiles Bitcoin mining production is currently operating at an... More
Heron Therapeutics (HRTX) PT Lowered to $40 at Evercore ISI
March 1, 2022 4:32 AM ESTEvercore ISI lowered its price target on Heron Therapeutics (NASDAQ: HRTX) to $40.00 (from $60.00) while maintaining a Outperform rating.... More
Heron Therapeutics (HRTX) Tops Q4 EPS by 4c
February 28, 2022 4:28 PM ESTHeron Therapeutics (NASDAQ: HRTX) reported Q4 EPS of ($0.54), $0.04 better than the analyst estimate of ($0.58). Revenue for the quarter came in at $20.66 million versus the consensus estimate of $25.59 million.
For earnings history and earnings-related data on Heron Therapeutics (HRTX) click here.
... More